TOP STORY

FDA guidance on abuse-deterrent opioids

FDA issued a draft guidance on Jan. 9 to help industry in the development of opioid drug formulations with abuse-deterrent properties, saying it considers development of these products a high public health priority. » More

Continuing Education

New CPE Series: January activity available now

Welcome to the fifth activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The January activity covers macrovascular and microvascular complications of diabetes mellitus.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

Color of generic drugs may affect adherence

Changes in tablet color significantly increase the odds that patients will stop taking their medications, according to a study published online first Dec. 31, 2012, in JAMA Internal Medicine (formerly known as the Archives of Internal Medicine). » More

Naloxone reduces heroin overdose deaths for low cost

Distributing naloxone to heroin users may be a cost-effective way to reduce the number of overdose deaths, a new study finds.
» More

SSRIs do not increase infant mortality risk

A recent study found no increased risk of stillbirth, neonatal death, or postneonatal death in infants born to women who used a selective serotonin reuptake inhibitor (SSRI) prescription during their pregnancies. » More

TAKE OUR SURVEY

Are you counseling more oncology patients to help with their medication regimens?

- Yes
- No

Click Here to let us know.

Check these out too

• Stricter rules for compounding industry

• AAP: Retain thimerosal for global vaccine

• Get back to good digestive health

• FDA: Record number of new drug approvals

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events